Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT05105412
Status:
TERMINATED
Last Update Posted:
2024-07-08
First Post:
2021-10-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Sponsor:
National Health Research Institutes, Taiwan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-07
First Submit QC Date:
None
Study First Post Date:
2021-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-03
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL